Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

NCT07122648 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Polymyositis
Dermatomyositis

Interventions

BIOLOGICAL: placebo
BIOLOGICAL: PN-101
BIOLOGICAL: PN-101

Sponsor

Paean Biotechnology Inc.